Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL7089262

O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.O=S(=O)(O)C(F)(F)F.[Al+3].[O-]c1cccc(F)c1.[O-]c1cccc(F)c1.[O-]c1cccc(F)c1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.47
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
KCNN4 O15554 4/20 0.36
ABCC9 O60706 1/20 0.35
ABCC8 Q09428 1/20 0.35
KCNJ11 Q14654 1/20 0.35
KCNJ8 Q15842 1/20 0.35
PARP1 P09874 1/20 0.35
CA12 O43570 3/20 0.35
CA1 P00915 3/20 0.35
CA2 P00918 3/20 0.35
CA9 Q16790 3/20 0.35
MEN1 O00255 2/20 0.33
RAB9A P51151 2/20 0.33
KMT2A Q03164 2/20 0.33
PTGS1 P23219 2/20 0.33
PTGS2 P35354 2/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL7089263 0.87 GPR3 (0.44) PTPN1CES2CES1ABCC9ABCC8
Trifluoromethanesulfonic Acid SCHEMBL7090348 0.81 PTPN1 (0.34) PTPN1CES2CES1CA12CA1
Trifluoromethanesulfonic Acid SCHEMBL7089026 0.81 PTPN1 (0.35) PTPN1GPR3
Trifluoromethanesulfonic Acid SCHEMBL7655778 0.79 GPR3 (0.41) PTPN1CES1CA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL7086263 0.77 ALDH1A1 (0.41) PTPN1CA12CA1CA2CA9
1-Hydroxy-3-Methoxybenzene SCHEMBL7085846 0.77 CES2 (0.41) CES2CES1ABCC9ABCC8KCNJ11
Trifluoromethanesulfonic Acid SCHEMBL7092452 0.77 L3MBTL1 (0.40) CA12CA1CA2CA9MEN1
Lithium Ion SCHEMBL31616118 0.76
SCHEMBL10487139 0.76
Trifluoromethanesulfonic Acid SCHEMBL28883024 0.72 TAAR1 (0.49) PTPN1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6624321-B2 Metathesis ring-opening polymerization of cyclic ethers in the presence of catalysts such as aluminum bis(trifluoromethane-sulfonate) phenolate BAYER AKTIENGESELLSCHAFT (DE) 2003-09-23 US disclosed
US-20030097026-A1 Process for the preparation of polyether polyols DENNINGER UWE (DE) 2003-05-22 US disclosed
US-6492565-B2 USING ALKYLENE OXIDE IN PRESENCE OF LEWIS ACID CATALYST BAYER AKTIENGESELLSCHAFT (DE) 2002-12-10 US disclosed
US-20010053866-A1 Process for the preparation of polyether polyols BAYER AKTIENGESELLSCHAFT (DE) 2001-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030097026-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 PTPN1 3839/4885CES2 826/4885CES1 1554/4885
US-20010053866-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 PTPN1 3839/4885CES2 826/4885CES1 1554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.